The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart disease.
Related Posts
Snap shares drop as FTC refers MyAI chatbot complaint to the DOJ
Snap shares closed down 5% on Thursday after the Federal Trade Commission said it would refer a complaint against the company to the Department of […]
Morgan Stanley says buy this digital health stock poised to rally more than 50%
Growth in Hims & Hers Health is showing no signs of stopping, according to Morgan Stanley.
Trump tariffs raise the specter of sharper economic downturn for South Korea and Japan
While South Korean imports to the U.S. face 25% tariffs, the same as Trump promised in April, the rate on Japan has been raised by […]